Publications.

Effectiveness and Cost-Effectiveness of 360 Disease-Modifying Treatment Escalation Sequences in Multiple Sclerosis

Simone Huygens 12/15/21 Simone Huygens 12/15/21

Effectiveness and Cost-Effectiveness of 360 Disease-Modifying Treatment Escalation Sequences in Multiple Sclerosis

Read More

The potential impact of digial biomarkers in multiple slerosis in the Netherlands: an early HTA technology assessment of MS Sherpa

Matthijs Versteegh 9/30/21 Matthijs Versteegh 9/30/21

The potential impact of digial biomarkers in multiple slerosis in the Netherlands: an early HTA technology assessment of MS Sherpa

Read More

Modeling the Cost-Utility of Treatment Sequences for Multiple Sclerosis

Simone Huygens 8/10/21 Simone Huygens 8/10/21

Modeling the Cost-Utility of Treatment Sequences for Multiple Sclerosis

Read More

Matthijs Versteegh 2/17/20 Matthijs Versteegh 2/17/20

Summarizing patient preferences for the competitive landscape of multiple sclerosis treatment options

Read More